This article was originally published in The Rose Sheet
Fragrance and flavors manufacturer will invest up to €46 mil. in German production sites over three years to "increase competitiveness," Symrise says. Initiative includes increasing employees' 37.5-hour workweek to 40 hours without wage increases and a two-year salary freeze. Firm also will receive government subsidies. Efforts will result in expanded production of fragrances and flavors at Symrise's Holzminden plant, consolidating natural flavor manufacturing at that site, but production also will continue at the Nordlingen facility...
You may also be interested in...
A draft Biosimilar Insulin Access Act, intended to waive US interchangeability requirements for FDA-approved biosimilar insulins, has been introduced by representative Glenn Grothman.
The former CEO of Cipla’s India business is set to steer JB Chemicals and Pharmaceuticals, as the Indian firm embarks on a new phase of growth, backed by a revamped board, following its takeover by US private equity firm KKR.
Moderna led by releasing the trial protocol for its COVID-19 vaccine study, followed by Pfizer, as industry faces demands for transparency.